The Effects of Surfactant on Oxygenation in Term Infants with Respiratory Failure

Objective The objective of the study was to evaluate the effects of exogenous surfactant on respiratory indices in term infants with respiratory failure. Methods Consecutive 18 mechanically ventilated term infants, who received a single dose of exogenous surfactant were retrospectively included into the study. The respiratory outcome of surfactant rescue therapy was evaluated by comparing respiratory indices before and six hours after surfactant administration. Findings Median oxygenation index (OI), mean alveolar pressure (MAP) and fraction of inspired oxygen (FiO2) values were significantly decreased (P<0.001); median arterial oxygen partial pressure (PaO2), arterial oxygen saturation (SaO2) and PaO2/FiO2 values were significantly increased six hours after surfactant treatment (P<0.001). Conclusion Rescue therapy with surfactant was found to be effective in the improvement of early respiratory indices in term infants with respiratory failure.

[1]  K. Tan,et al.  Surfactant for bacterial pneumonia in late preterm and term infants. , 2012, The Cochrane database of systematic reviews.

[2]  M. Kuzniewicz,et al.  Increased risk for respiratory distress among white, male, late preterm and term infants , 2012, Journal of Perinatology.

[3]  L. Miall,et al.  The management of respiratory distress in the moderately preterm newborn infant , 2011, Archives of Disease in Childhood: Education & Practice Edition.

[4]  F. Midulla,et al.  Old and new uses of surfactant , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[5]  O. Möller,et al.  Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome , 2002, Acta paediatrica.

[6]  C. Ruppert,et al.  Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties , 2002, European Respiratory Journal.

[7]  O. Gefeller,et al.  Surfactant Treatment of Neonates With Respiratory Failure and Group B Streptococcal Infection , 2000, Pediatrics.

[8]  A. Jobe.  Commentary on Surfactant Treatment of Neonates With Respiratory Failure and Group B Streptococcal Infection , 2000, Pediatrics.

[9]  E. Özek,et al.  Prophylactic animal derived surfactant extract for preventing morbidity and mortality in preterm infants , 1997 .

[10]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[11]  H. Schwarz,et al.  Surfactant Substitution in Ventilated Very Low Birth Weight Infants: Factors Related to Response Types , 1991, Pediatric Research.

[12]  A. Jobe.  Chapter 4 – Surfactant: The Basis for Clinical Treatment Strategies , 2008 .

[13]  R. Soll,et al.  Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. , 2000, The Cochrane database of systematic reviews.

[14]  D. Bulas,et al.  Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. , 1998, The Journal of pediatrics.